Endoscopy is a minimally invasive procedure which are being practiced in many gastroenterology and pulmonary surgical procedures. Balloon dilators are used in these endoscopic procedures and is carried out under fluoroscopic endoscopic guidance. Endoscopic balloon dilators are offered as single use medical device and it is also considered as one-time healthcare gadgets. The balloon is expanded with the help of water, saline, or other fluid materials. Advancement in technology in endoscopy balloon dilators offers various advantages such as combined outstanding trackability, fluoroscopic visualization. These dilators are available in various sizes, designs, and lengths. These balloon dilators provide advantages over traditional surgical procedure which is also known as a minimal invasive procedure as it allows to avoid the traditional surgeries. Balloon dilatation catheter are carried out by dilatation of strictures located in the esophagus, pylorus, duodenum, colon, and the airway tree. These balloon dilators are versatile and are used by combining with the easy to use balloon dilation with irrigation suction, and CT image guidance. The endoscopic balloon dilators also help in opacification during many endoscopic procedures
Furthermore, the advancements in the endoscopic procedures and the increasing demand for minimally invasive procedures over the conventional surgical procedures through endoscopic balloon dilation and increasing incidence of chronic diseases are propelling the market growth of endoscopic balloon dilator market. Minimally invasive surgeries accounted for approximately 86% of total robotic surgeries performed in the United States in the year 2017. Moreover, endoscopic procedures are also being carried out in many ASCs which is further propelling the market growth of endoscopic balloon dilator market.
The global endoscopic balloon dilator market is expected to grow at a CAGR of around 7.5% over the period of next 5 years.
Get a brochure of this research study Click Here
The market growth endoscopic balloon dilator is attributed to key factors such as rising demand for minimally invasive surgeries, advantages of these surgeries over conventional mode of dilation, increasing prevalence of chronic diseases that demands for minimally invasive surgeries and technological advancements in endoscopic balloon dilators. For instance, Boston Scientific introduced the CRE pulmonary balloon dilatation catheter which is intended to be used to endoscopically dilate strictures of the airway tree built with three-in-one technology and provides successive, gradual dilation of strictures.
Furthermore, increasing number of minimally invasive surgeries globally is also a contributing factor for the market growth. For instance, according to the organization plastic surgery, approximately 7.7 million cosmetic minimally invasive procedures were performed in the year 2019. Such rising trend of these procedures is propelling the market growth of endoscopic balloon dilator.
ENDOSCOPIC BALLOON DILATOR MARKET SEGMENTATION:
By Product Type:
- Biliary balloon dilator
- Esophageal balloon dilator
- Pyloric balloon dilator
- Colonic balloon dilator
- Duodenal balloon dilator
By Modality Type:
- Single Lumen
- Double Lumen
By End user:
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
North America is projected to gain dominance in the endoscopic balloon dilator market. The market growth in this region can be attributed to increasing prevalence of various gastrointestinal stenosis conditions, growing minimally invasive procedures, high adoption of endoscopic techniques coupled with rising healthcare expenditure. In April 2019, approximately, 75 million endoscopies were performed in the U.S. and around 51.5 million (68%), accounted for gastrointestinal endoscopies. This factor is projected to fuel the market growth in the near future.
Asia Pacific endoscopic balloon dilator market is anticipated to exhibit the fastest growth in the coming years. The fastest growth can be attributed to the rising demand for minimally invasive procedures coupled with increase patient population suffering from gastrointestinal disorders that requires endoscopic dilation. Furthermore, Asia Pacific region is observed to be the fastest growing regional market for endoscopic balloon dilator due to rapid improvement in medical device industry and rising healthcare spending by the government. This region is expected to maintain its growth rate in the near future.
FEW KEY PLAYERS IN CYTOMEGALOVIRUS ASSAY MARKET:
- Boston Scientific Corporation
- Olympus Medical Corporation
- Merit Medical Endotek
- Cook Medical
- CONMED Corporation
- HOBBS MEDICAL INC.
- Medi-Globe GmbH
- PanMed US
In December 2020, Micro-Tech Endoscopy USA introduced a new dilation product such as GI Dilation category. This category includes ABC Balloon, which is available in 6 diameter sizes, all with a balloon length of 5.5 cm. The balloon has a working length of 230 cm, and can be used for esophageal, pyloric or colonic dilation. The company operates in other geographical regions such as America, Europe, Asian countries and with this innovation company widened its product portfolio in the endoscopic balloon market.
In June 2016, Medtronic company announced the US FDA launch of NuVent sinus dilation balloon dilators. Patients with scarred, granulated or previously surgically altered tissue was selected for the treatment. The device is also the only balloon sinus dilation system made with built-in electromagnetic surgical navigation that allows surgeons to confirm sinus anatomy and place the balloon during surgery. The device also uses an image guidance technology called Fusion, which reveals a “map” of the sinus anatomy, thereby helping physicians specifically to target points in blocked sinuses for dilation during minimally invasive surgery